CD5-negative blastoid variant mantle cell lymphoma with complex CCND1/IGH and MYC aberrations. Ann Lab Med. 2012; 32 :95–98... Yoonmi,Seok,Juwon,... - 《Annals of Laboratory Medicine》 被引量: 10发表: 2012年 Leukemic phase of mantle cell lymphoma, blastoid variant. Six patients with...
CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma: a clinicopathologic study of 14 cases. Hum Pathol 2012;43:1436-43.Jaso J, Chen L, Li S, Lin P, Chen W, Miranda RN, et al. CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma: a clinicopathologic study of 14 ...
Although CD10 is infrequently positive in follicular lymphoma, the morphology, immunohistochemistry, the presence of plasmacytoid cells and lymphoepithelial lesions are in favor of MALT lymphoma rather than follicular lymphoma. The present tumor is not mantle cell lymphoma, because of negative cyclin D1...
CD5-positive marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT) of the lung is very rare. An 82-year-old Japanese woman was found to have an abnormal lung shadow on chest X-ray photography, and was admitted to our hospital. Imaging modalities including X-ray pho...
Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+ and CD5 with CD10+ groups may constitute clinically relevant subtypes. Leukemia. 1999; 13: 1441-1447.Harada S, Suzuki R, Uehira K, Yatabe Y, Kagami Y, Ogura M, Suzuki H, Oyama A, Kodera Y, Ueda R, ...
Her hematogones expressed the T-cell marker CD5 as well as CD19, CD10, and CD20, and terminal deoxynucleotidyl transferase and HLA-DR. These findings suggest that hematogones are precursors of both CD5-positive B cells and CD5-negative B cells. Thus CD5-positive B cells in bone marrow ...
Typically, the neoplastic MALT lymphoma cells coexpress CD20+ and surface light-chain restriction but are negative for CD10 and CD5. Some researchers have documented expression of CD5 in MALT lymphomas, which is rare. Aberrant CD5-expression is thought to be a marker of early dissemination and...
Introduction: There are various poor prognosis factors in diffuse large B cell lymphoma (DLBCL). CD5 positive (CD5+) is estimated as one of the poor prognosis markers in DLBCL. CD5+ DLBCL is completely distinguished from CLL or Mantle cell lymphoma, and de Novo CD5+ DLBCL is related to...
The lymphoma consists of grade 3B (80–90%, a,b) and diffuse large B-cell lymphoma (10–20%, c,d). Immunostains show that the lymphoma cells are positive for CD20 (e), weakly positive for CD5 (f), and are negative for CD3 (g). An antibody for Ki-67 (MIB-1) shows that ~...
目的:研究原发 CD5阳性弥漫大 B 细胞淋巴瘤(CD5-positive diffuse large B cell lymphoma,CD5+DLBCL)的临床,免疫表型,细胞遗传学特点及治疗反应和预后.方法:回顾分析7例通过免疫组化和流式细胞免疫分析确诊的 CD5+DLBCL 的临床和免疫表型特点,细胞遗传学异常及治疗和预后.结果:7例患者中位年龄70岁.3例以淋巴...